Pluripotent stem cells: biology and applications: Durango Colorado, 6-11 February 2001

Por Doevendans, P.A.F.M., Mummery, C.L.
Publicado em 2001

Intracoronary abciximab

Por Bustillo, S. Ruiz, Stella, P., Doevendans, P.A.F.M.
Publicado em 2006

Clinical cardiogenetics

Por Baars, H. F., Doevendans, P. A. F. M., van der Smagt, J. J.
Publicado em c201

Regulation and characteristics of vascular smooth muscle cell phenotypic diversity

Por Rensen, S.S.M., Doevendans, P.A.F.M., van Eys, G.J.J.M.
Publicado em 2007

Peripartum cardiomyopathy: the need for a national database

Por Lok, S. I., Kirkels, J. H., Klöpping, C., Doevendans, P. A. F., de Jonge, N.
Publicado em 2011

Ten-year mortality risk of patients undergoing elective PCI: long-term follow-up of the GENetic Determinants of Restenosis (GENDER) study: No increased mortality risk by restenosis...

Por Verschuren, J. J. W., Trompet, S., Tio, R. A., de Winter, R. J., Doevendans, P. A. F. M., Jukema, J. W.
Publicado em 2012

Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?

Por Wijers, S. C., van der Kolk, B. Y. M., Tuinenburg, A. E., Doevendans, P. A. F., Vos, M. A., Meine, M.
Publicado em 2013

Progress in noninvasive coronary artery imaging using multislice CT

Por Meijs, M.F.L., de Vos, A.M., Rutten, A., Prokop, M., Cramer, M.J.M., Doevendans, P.A.F.M.
Publicado em 2005

Left ventricular assist device: a functional comparison with heart transplantation

Por Pruijsten, R.V., de Jonge, N., Kirkels, J.H., Klöpping, C., Doevendans, P.A.F.M., Oosterom, A., Kemperman, H., Lahpor, J.R.
Publicado em 2008

Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells

Por Vrijsen, K R, Sluijter, J P G, Schuchardt, M W L, Van Balkom, B W M, Noort, W A, Chamuleau, S A J, Doevendans, P A F M
Publicado em 2010

No psychological distress in sportsmen aged 45 years and older after cardiovascular screening, including cardiac CT: The Measuring Athlete’s Risk of Cardiovascular events (MARC) st...

Por Schurink, M. M., Braber, T. L., Prakken, N. H. J., Doevendans, P. A. F. M., Backx, F. J. G., Grobbee, D. E., Rienks, R., Nathoe, H. M., Bots, M. L., Velthuis, B. K., Mosterd, A.
Publicado no Neth Heart J (2017)

Heart transplantation in the Netherlands: quo vadis?

Por Kirkels, J.H., de Jonge, N., Klöpping, C., Lahpor, J.R., van Herwerden, L.A., Balk, A.H.M.M., Bogers, A.J.J.C., Maat, A.P.W.M., Doevendans, P.A.F.M.
Publicado em 2006

Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study: The role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen

Por Braber, T. L., Mosterd, A., Prakken, N. H. J., Doevendans, P. A. F. M., Mali, W. P. Th. M., Backx, F. J. G., Grobbee, D. E., Rienks, R., Nathoe, H. M., Bots, M. L., Velthuis, B. K.
Publicado no Neth Heart J (2014)

Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years

Por Hendrix, A., van der Werf, C., Bots, M.L., Birnie, E., van der Smagt, J.J., Borleffs, C.J.W., Vink, A., van Weert, H.C., Doevendans, P.A.F.M., Wilde, A.A.M., Mosterd, A., van Langen, I.M.
Publicado em 2010

Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining G...

Por Verschuren, J.J.W., Sampietro, M.L., Pons, D., Trompet, S., Ewing, M.M., Quax, P.H.A., de Knijff, P., Zwinderman, A.H., de Winter, R.J., Tio, R.A., de Maat, M.P., Doevendans, P.A.F.M., Jukema, J.W.
Publicado em 2010